First time post, but wanted to bring more attention to a biotech stock that I personally love.
ABCL is not a biotech company, nor is it a pharma company. They want to be both, they want to make data, make drugs, make new scientific discoveries, they want royalties, partnerships, research. This company has huge plans and is in the right spot financially to make it all happen.
Check out their earnings:
ABCL (Link to Earnings) TLDR its fucking massive, its a phenomenal report. 800 million on hand with Little debt with the debt at 0% interest. 0. F'ing. Percent. (Link to pretty color ppt from earnings call)
ABCL has huge potential to become a massive juggernaut as a biotech/pharma company.
Their antibody discovery platform allows them to rapidly discover therapeutic targets and push them into preclinical development. This is best demonstrated by the development of Bamlanivimab, where the antibody went from unknown to discovered product to clinical trials in 60 days. 60. days. Typical drug development takes years on average and they had a covid drug in clinical trials by the summer of 2020 after starting discovery efforts in late winter.
Let me start a new paragraph and reemphasize this shit 60. F'ing. Days. Thats the definition of industry disruption, to introduce a new product that drastically improves and decreases development time is huge. I fucking snorted the crayons (orange you tards any other flavor isn't worth the time) out of my nose when I saw this, full disclosure I work in the industry and we can't fucking match this.
And since I know most of you can't read, here's a couple bullet points your partner's girlfriend or boyfriend can read to you tonight:
- ABCL 2020 Annual Revenue was $233,155,000.
- ABCL 2021 Q1 Project Revenue from one income stream AKA Bamlamni-60fuckingday-cumfasterthanyourpreeteen-vimab is a minimum of 190,000,000, more likely over 200mil.
Their projected 2021 Q1 revenue is essentially their whole entire year in 2020.
Now during the earnings call one investor had a decent slightly stoopid question of what about when COVID is over. Ladies and Gents sit down and shut up. COVID is projected to be endemic for the decade if not forever, it is here to stay. Which means COVID drugs are here to stay and here to generate money. The CEO made sure to point this out, also that ABCL is not a fucking COVID company. They many projects in different fields of therapeutics (oncology, animal health, nerve regeneration, etc) and they acquired a company called Trianni last year. A humanized mouse model company that OTHER companies will use for research and drug development.
If my retard summaries above weren't enough check out the historical short volume data. If you wanted squeeze potential, ABCL might just have a bunch of lemons so find some fucking sugar, ice cubes, and water. Might just be drinking some lemonade on the porch of your 100 year old dilapidated Southern Style farm house porch of a home that you bought with 5% interest with a waived inspection and no DIY skills to speak of.
TLDR
I like the stonk. Not a financial advisor. Just a smooth brained amc holding ape.
ABCL 380 shares and counting avg 34.70.